StockNews.com started coverage on shares of Applied DNA Sciences (NASDAQ:APDN – Free Report) in a research report sent to investors on Saturday. The firm issued a sell rating on the technology company’s stock.
Separately, HC Wainwright lowered their price objective on shares of Applied DNA Sciences from $7.00 to $1.50 and set a buy rating for the company in a research note on Monday, June 10th.
View Our Latest Report on APDN
Applied DNA Sciences Price Performance
Applied DNA Sciences (NASDAQ:APDN – Get Free Report) last posted its quarterly earnings data on Friday, May 10th. The technology company reported ($5.31) EPS for the quarter, missing the consensus estimate of ($4.60) by ($0.71). Applied DNA Sciences had a negative return on equity of 306.32% and a negative net margin of 222.33%. The company had revenue of $0.93 million for the quarter, compared to analyst estimates of $0.90 million. On average, sell-side analysts expect that Applied DNA Sciences will post -2.95 EPS for the current year.
Institutional Investors Weigh In On Applied DNA Sciences
A hedge fund recently bought a new stake in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC bought a new stake in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned 0.72% of Applied DNA Sciences at the end of the most recent reporting period. Institutional investors own 22.22% of the company’s stock.
About Applied DNA Sciences
Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.
Further Reading
- Five stocks we like better than Applied DNA Sciences
- How to Invest in the FAANG Stocks
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- What Makes a Stock a Good Dividend Stock?
- MarketBeat Week in Review – 6/24 – 6/28
- Top Biotech Stocks: Exploring Innovation Opportunities
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Receive News & Ratings for Applied DNA Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied DNA Sciences and related companies with MarketBeat.com's FREE daily email newsletter.